Evidence map›Paper›PMID 31316150›Full record

ArticleScientific reports2019

Uncoupling of p97 ATPase activity has a dominant negative effect on protein extraction.

Halley B Rycenga, Kelly B Wolfe, Elizabeth S Yeh, David T Long

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Halley B RycengaDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA.
Kelly B WolfeDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA.
Elizabeth S YehDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
David T LongDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. longdt@musc.edu.
Medical University of South Carolina · USIndiana University School of Medicine

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Connecting BRCA1 functions with DNA crosslink sensitivityR35GM119512 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LONG, DAVID THOMAS · 2016 to 2025
$3.9M
Integrative Training in Oncogenic SignalingT32CA193201 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWE, PHILIP H, LONG, DAVID THOMAS · 2016 to 2025
$3.7M
Overcoming Resistance in HER2-positive Breast CancerR01CA187305 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YEH, ELIZABETH S · 2015 to 2019
$1.8M
NCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450NCI NIH HHS R01 CA187305NCI NIH HHS T32 CA193201NIGMS NIH HHS R35 GM119512
6 · The paper itself

Abstract

p97 is a highly abundant, homohexameric AAA+ ATPase that performs a variety of essential cellular functions. Characterized as a ubiquitin-selective chaperone, p97 recognizes proteins conjugated to K48-linked polyubiquitin chains and promotes their removal from chromatin and other molecular complexes. Changes in p97 expression or activity are associated with the development of cancer and several related neurodegenerative disorders. Although pathogenic p97 mutations cluster in and around p97's ATPase domains, mutant proteins display normal or elevated ATPase activity. Here, we show that one of the most common p97 mutations (R155C) retains ATPase activity, but is functionally defective. p97-R155C can be recruited to ubiquitinated substrates on chromatin, but is unable to promote substrate removal. As a result, p97-R155C acts as a dominant negative, blocking protein extraction by a similar mechanism to that observed when p97's ATPase activity is inhibited or inactivated. However, unlike ATPase-deficient proteins, p97-R155C consumes excess ATP, which can hinder high-energy processes. Together, our results shed new insight into how pathogenic mutations in p97 alter its cellular function, with implications for understanding the etiology and treatment of p97-associated diseases.

Indexed as

Adenosine TriphosphatasesAmino Acid SubstitutionAnimalsCell Line, TumorChromatinDNAFemaleHumansIn Vitro TechniquesMutant ProteinsMutation, MissenseNeoplasmsNuclear ProteinsOocytesProtein SubunitsRecombinant ProteinsAdenosine TriphosphatasesChromatinDNAMutant ProteinsNuclear Proteinsp97 ATPaseProtein SubunitsRecombinant ProteinsUbiquitin

Identifiers

PMID31316150
PMCPMC6637110
OpenAlexW2957736282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.